ADVMAdverum Biotechnologies, Inc.

ADVM Stock Price, Valuation & Chart | Adverum Biotechnologies, Inc.

Compare

$4.360+0.00 (+0.00%)

At close · 09 Dec 2025, 09:00 pm

Sector: Healthcare Industry: Biotechnology ADVM intrinsic value ADVM calculated fair value vs price

Overview Financials Dividends Ratios

ADVM Historical price chart

ADVM Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization96.26M

PE Ratio-0.51

EPS-8.57

Trading Volume675.98K

Today's High/Low4.36/4.24

Dividend Yield0.00

52 Week High/Low6.07/1.78

Shares Outstanding22.08M

ADVM Financial Statement

ADVM Analyst ratings

ADVM Analysis & performance metrics

ADVM Company profile

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate…

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum…

ADVM Management team

Name

Position

Carla Fiankan

Senior Vice President of Regulatory Affairs

Romuald Corbau Ph.D.

Chief Scientific Officer

Aneta Ferguson

General Counsel

Laurent FischerCEO

President, Chief Executive Officer & Director

R. Andrew Ramelmeier Ph.D.CTO

Chief Technology Officer

Dena House

Chief People Officer

Linda M. Rubinstein M.A.CFO

Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer

Rabia Gurses Ozden M.D.

Chief Medical Officer

Name

Position

Carla Fiankan

Senior Vice President of Regulatory Affairs

Romuald Corbau Ph.D.

Chief Scientific Officer

Aneta Ferguson

General Counsel

Laurent FischerCEO

President, Chief Executive Officer & Director

R. Andrew Ramelmeier Ph.D.CTO

Chief Technology Officer

Dena House

Chief People Officer

Linda M. Rubinstein M.A.CFO

Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer

Rabia Gurses Ozden M.D.

Chief Medical Officer

Management Team

Carla Fiankan

Senior Vice President of Regulatory Affairs

Romuald Corbau Ph.D.

Chief Scientific Officer

Aneta Ferguson

General Counsel

Laurent FischerCEO

President, Chief Executive Officer & Director

R. Andrew Ramelmeier Ph.D.CTO

Chief Technology Officer

Dena House

Chief People Officer

Linda M. Rubinstein M.A.CFO

Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer

Rabia Gurses Ozden M.D.

Chief Medical Officer

Management

Carla Fiankan

Senior Vice President of Regulatory Affairs

Romuald Corbau Ph.D.

Chief Scientific Officer

Aneta Ferguson

General Counsel

Laurent FischerCEO

President, Chief Executive Officer & Director

R. Andrew Ramelmeier Ph.D.CTO

Chief Technology Officer

Dena House

Chief People Officer

Linda M. Rubinstein M.A.CFO

Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer

Rabia Gurses Ozden M.D.

Chief Medical Officer

Total 8 executives

ADVM Frequently asked questions

What is Adverum Biotechnologies, Inc. (ADVM) Stock Price?

Current stock price of Adverum Biotechnologies, Inc. (ADVM) stock is $4.360. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Adverum Biotechnologies, Inc. (ADVM) stock is 675.98K.

Last updated at 09 Dec 2025, 09:00 pm.

Why is the Adverum Biotechnologies, Inc. (ADVM) stock price going up or down today?

The stock price of Adverum Biotechnologies, Inc. (ADVM) can change with earnings, company news, and overall market sentiment. Adverum Biotechnologies, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Adverum Biotechnologies, Inc. stock expensive at its current price?

Whether Adverum Biotechnologies, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ADVM on this page is -0.51. EPS on this page is -8.57. Compare those figures with peers and growth expectations before deciding if the current Adverum Biotechnologies, Inc. price is justified.

How has the stock price of Adverum Biotechnologies, Inc. (ADVM) performed historically?

Historical performance for Adverum Biotechnologies, Inc. (ADVM) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ADVM reacted to past earnings and market events.

Should I buy Adverum Biotechnologies, Inc. (ADVM) stock, at this price?

Buying Adverum Biotechnologies, Inc. (ADVM) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.